Health and Fitness

Experimental Dengue Vaccine Protects All Recipients in Virus Challenge Study

Vaccine developed by NIH and FDA scientists

Image of a female Aedes mosquito A female Aedes mosquito, which spreads dengue virusNIAID

Bethesda, Maryland–(ENEWSPF)–March 17, 2016.  A clinical trial in which volunteers were infected with dengue virus six months after receiving either an experimental dengue vaccine developed by scientists from the National Institutes of Health (NIH) or a placebo injection yielded starkly contrasting results. All 21 volunteers who received the vaccine, TV003, were protected from infection, while all 20 placebo recipients developed…

Proud member of LION Publishers

Most read stories this week

Take a Survey

ARCHIVES